Accuracy and Reduced Sleep Disruption of a Wearable Smartwatch for Nocturnal Blood Pressure Monitoring: A Validation Study
The Journal of Clinical Hypertension · 2025
DOI: 10.1111/jch.70183 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Yanbo Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Healthcare, Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Blood Pressure Monitoring, Ambulatory, Sleep Deprivation, Wearable Electronic Devices. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Huawei Device Co. Ltd.
Abstract (Originalsprache)
Nocturnal blood pressure is a significant predictor of cardiovascular risk, but traditional ambulatory blood pressure monitoring (ABPM) can disrupt sleep. This study aimed to validate the accuracy of the Huawei Watch D2 (WD2), a wrist‐worn oscillometric device, and assess its impact on sleep quality compared to conventional ABPM. This prospective, single‐center trial first validated the WD2 against a mercury sphygmomanometer in 85 participants according to ANSI/AAMI/ISO 81060‐2:2018 standards in both seated and supine positions. Subsequently, the device's nocturnal accuracy and sleep impact were compared against a traditional ABPM device in 46 participants over a three‐night protocol. The WD2 met all ISO accuracy standards. During nighttime monitoring, there was no significant difference between the WD2 and ABPM for mean systolic or diastolic blood pressure. However, the number of awakenings was significantly lower on nights with the WD2 alone compared to nights with the ABPM device ( p = 0.016). In conclusion, the Huawei Watch D2 is a clinically validated device that provides nocturnal blood pressure readings comparable to traditional ABPM with the significant advantage of minimal sleep disruption, positioning it as a valuable alternative for nocturnal hypertension monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Healthcare, Peking Union Medical College Hospital, Beijing, China.
- Department of Cardiology, Peking Union Medical College Hospital, Beijing, China.
- International Medical Services, Peking Union Medical College Hospital, Beijing, China.
Förderung
- Huawei Device Co. Ltd
Zitieren
APA
Liu, Y., Lu, Y., Wu, J., Zhang, T., Wang, B., & Tian, Z. (2025). Accuracy and Reduced Sleep Disruption of a Wearable Smartwatch for Nocturnal Blood Pressure Monitoring: A Validation Study. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70183
Vancouver
Liu Y, Lu Y, Wu J, Zhang T, Wang B, Tian Z. Accuracy and Reduced Sleep Disruption of a Wearable Smartwatch for Nocturnal Blood Pressure Monitoring: A Validation Study. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70183
BibTeX
@article{Liu2025,
author = {Liu, Yanbo and Lu, Yang and Wu, Jiabo and Zhang, Tian and Wang, Beibei and Tian, Zhuang},
title = {Accuracy and Reduced Sleep Disruption of a Wearable Smartwatch for Nocturnal Blood Pressure Monitoring: A Validation Study},
journal = {The Journal of Clinical Hypertension},
year = {2025},
doi = {10.1111/jch.70183}
}
EUVIMED